One underlying mechanism is the direct reduction in eNOS caused by inflammatory mediators (e.g., TNF-α, IL-6, and CRP), which are usually elevated under inflammatory conditions.139 Consequently, the proinflammatory matrix and cellular modifications lead to the progression of hypertension and atherosclerosis.14 This evidence concerns the gene CRP and atherosclerosis.